These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23627635)

  • 21. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
    Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
    Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44s and CD44v6 expression in head and neck epithelia.
    Mack B; Gires O
    PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model.
    Geißler C; Hambek M; Leinung M; Diensthuber M; Gassner D; Stöver T; Wagenblast J
    In Vivo; 2012; 26(4):593-8. PubMed ID: 22773573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.
    Chiu CC; Lee LY; Li YC; Chen YJ; Lu YC; Li YL; Wang HM; Chang JT; Cheng AJ
    Cancer Gene Ther; 2013 Nov; 20(11):606-15. PubMed ID: 24201869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
    Wang SJ; Wreesmann VB; Bourguignon LY
    Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells.
    Lee SH; Nam HJ; Kang HJ; Samuels TL; Johnston N; Lim YC
    Oncol Rep; 2015 Oct; 34(4):2065-71. PubMed ID: 26239260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Prince ME; Sivanandan R; Kaczorowski A; Wolf GT; Kaplan MJ; Dalerba P; Weissman IL; Clarke MF; Ailles LE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):973-8. PubMed ID: 17210912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.
    Assimakopoulos D; Kolettas E; Patrikakos G; Evangelou A
    Histol Histopathol; 2002 Oct; 17(4):1269-81. PubMed ID: 12371152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
    Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
    J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1.
    Chen YC; Chang CJ; Hsu HS; Chen YW; Tai LK; Tseng LM; Chiou GY; Chang SC; Kao SY; Chiou SH; Lo WL
    Oral Oncol; 2010 Mar; 46(3):158-65. PubMed ID: 20036608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.
    Duarte S; Loubat A; Momier D; Topi M; Faneca H; Pedroso de Lima MC; Carle GF; Pierrefite-Carle V
    Oncol Rep; 2012 Sep; 28(3):1057-62. PubMed ID: 22825753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer.
    Koukourakis MI; Giatromanolaki A; Tsakmaki V; Danielidis V; Sivridis E
    Br J Cancer; 2012 Feb; 106(5):846-53. PubMed ID: 22333601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells in head and neck squamous cell carcinoma.
    Shakib K; Schrattenholz A; Soskic V
    Br J Oral Maxillofac Surg; 2011 Oct; 49(7):503-6. PubMed ID: 20832149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.